AbbVie Partners With Iambic to Accelerate AI-Driven Drug Discovery

01 AbbVie collaborates with Iambic to enhance AI-driven small-molecule drug discovery in key therapeutic areas.

02 Utilize Iambic's Enchant v3 AI model to improve drug discovery efficiency and innovation.

03 AbbVie contributes its expertise while Iambic provides advanced AI technologies and automated capabilities.

04 Financial terms include upfront payments and success-based milestones, although specific values remain undisclosed.

05 Partnership announcement coincided with the launch of Iambic's latest AI model, demonstrating ongoing innovation.

The full story AbbVie Partners With Iambic to Accelerate AI-Driven Drug Discovery Read the story